中国日报网43 分钟
First bivalent mRNA vaccine candidate against RSV goes under clinical trial
The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...
News Medical8 分钟
Inequities in COVID-19 vaccination coverage for older adults highlighted in global study
COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...